AMA warns CVS-Aetna merger will raise drug plan, PBM prices

An American Medical Association analysis determined the CVS-Aetna merger would substantially weaken competition and raise prices for Medicare Part D prescription drug plans and pharmacy benefit management services.

Read the full post at Modern Healthcare Breaking News
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive